Acetyl L-Carnitine & Alpha-Lipoic Acid
Product analysis
Acetyl L-Carnitine & Alpha-Lipoic Acid pairs ingredients involved in cellular energy and antioxidant processes. Routine energy or focus benefits in healthy adults remain uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality34
The carnitine and calcium forms are identified, but their preparation quality cannot be judged confidently. The alpha-lipoic acid form is unspecified, leaving that part of the combination less clear.
Ingredient Transparency88
All listed amounts and the carnitine and calcium forms are disclosed. The alpha-lipoic acid form is unspecified, limiting a precise comparison with other combinations.
Value For Money60
The carnitine has a reasonably competitive cost for its declared amount. The other ingredients lack dependable comparisons to establish the value of the complete formula.
Customer Satisfaction85
Customer feedback is favorable across thousands of ratings. The broad review base supports the satisfaction pattern without proving energy or cognitive benefits.
Product Focus52
Carnitine gives the formula a plausible connection to energy handling and cognition. The main fatigue findings involve clinical populations, so ordinary energy, memory and productivity benefits in healthy adults remain uncertain.
- Format
Tablet - Container
- 60 Tablet(s)
- Per serving
- $0.33
- Customer rating
- 4.6 · 3,402 ratings
Goals
Acetyl L-carnitine has a biological connection to cellular energy handling. The 500 mg serving is recognized in the saved assessment, but the supplied fatigue evidence concerns older adults with clinical fatigue and does not establish a routine energy boost in healthy adults.
How this product is rated for Energy
Ingredient fit51
Goal fit
Dose adequacy
Pathways40
Depth
Breadth
Evidence95
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Acetyl L-carnitine relates to brain energy metabolism. The 500 mg serving offers partial dose support, while evidence from clinical populations does not establish routine cognitive benefit for healthy adults.
How this product is rated for Brain Health
Ingredient fit51
Goal fit
Dose adequacy
Pathways19
Depth
Breadth
Evidence76
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Acetyl L-carnitine at 500 mg and alpha-lipoic acid at 150 mg relate to mitochondrial energy processes and antioxidant activity. Their biological roles and selected disease-cohort findings do not establish routine preservation of function or longer life in healthy adults.
How this product is rated for Longevity
Ingredient fit58
Goal fit
Dose adequacy
Pathways11
Depth
Breadth
Evidence63
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Acetyl L-carnitine is connected with cellular energy and acetylcholine-related processes. The 500 mg serving has a possible cognitive rationale, but the supplied clinical evidence does not establish a routine focus or memory benefit for healthy adults.
How this product is rated for Cognitive Support
Ingredient fit51
Goal fit
Dose adequacy
Pathways40
Depth
Breadth
Evidence79
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Acetyl L-carnitine at 500 mg relates to cellular energy and acetylcholine production. These functions provide a plausible connection to cognition, while direct support for an immediate improvement in everyday focus remains limited.
How this product is rated for Mental Focus
Ingredient fit51
Goal fit
Dose adequacy
Pathways40
Depth
Breadth
Evidence83
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calcium (Dibasic Calcium Phosphate) | 23 mg | |
Acetyl L-Carnitine (Acetyl L-Carnitine HCl) | 500 mg | |
Alpha-Lipoic Acid | 150 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability88
ALCAR vs. Standard Carnitine Form
Advanced Sourcing and Salt Specificity
Dose, Safety & Label Transparency100
Clinical Dosage Efficacy
Label Transparency and Proprietary Blends
Value75
Price per 500mg Acetyl L-Carnitine
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
- Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
- Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
- Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
- Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
- A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
- Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
- Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
- The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
- Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
- A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
- Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review.
- Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.
- Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.
- [Psycho-functional changes in attention and learning under the action of L-acetylcarnitine in 17 young subjects. A pilot study of its use in mental deterioration].
- Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
- Acetyl-L-carnitine for patients with hepatic encephalopathy.
- Low Bioavailability and High TMAO Production: Novel Insights Into Acetylcarnitine and Carnitine Metabolism.